RT - Journal Article T1 - Outcomes of Surgical Excision and High-Dose-Rate Brachytherapy for Earlobe Keloids JF - World-J-Plast-Surg YR - 2021 JO - World-J-Plast-Surg VO - 10 IS - 1 UR - http://wjps.ir/article-1-636-en.html SP - 78 EP - 84 K1 - Earlobe keloid K1 - Excision K1 - High-dose-rate brachytherapy K1 - Plastic surgery AB - BACKGROUND Radiotherapy as an adjuvant therapy to surgical resection has shown variable rates of recurrence treating earlobe keloids. The purpose of this study was to describe our experience with surgical excision followed by high-dose-rate brachytherapy and present our outcomes after 24 months of follow-up. METHODS Retrospective chart of 14 patients with 14 earlobe keloids treated with surgical excision followed by high-dose-rate brachytherapy, between January 2015 and May 2016 were enrolled. Database included demographics, Fitzpatrick skin type, laterality, lesion size, and follow-up visits information. Outcomes were assessed in terms of keloid recurrence rates, complications, and patient subjective aesthetical result satisfaction after 24 months of follow-up. RESULTS All procedures were completed without complications. Three patients experienced keloid recurrence after 6 (14.28%) and 12 months (7.14%). Three patients experienced mild signs of self-limited post-radiation dermatitis. Self-assessment of aesthetical result was considered “very good” in 71.43% of patients. CONCLUSION Surgical excision followed by high-dose-rate brachytherapy is secure and effective to treat earlobe keloids, and can be considered a first line combined treatment. Larger clinical trials comparing different irradiation protocols are still needed. LA eng UL http://wjps.ir/article-1-636-en.html M3 10.29252/wjps.10.1.78 ER -